294 related articles for article (PubMed ID: 84470)
1. Mycosis fungoides plaque stage treated with topical nitrogen mustard with and without attempts at tolerance induction: report from the Scandinavian mycosis fungoides study group.
Molin L; Thomsen K; Volden G
Acta Derm Venereol; 1979; 59(1):64-8. PubMed ID: 84470
[TBL] [Abstract][Full Text] [Related]
2. Topical nitrogen mustard in mycosis fungoides.
Zachariae H
Int J Clin Pharmacol Res; 1985; 5(3):193-8. PubMed ID: 4018954
[TBL] [Abstract][Full Text] [Related]
3. Topical nitrogen mustard in early mycosis fungoides. A 12-year experience.
Zachariae H; Thestrup-Pedersen K; Søgaard H
Acta Derm Venereol; 1985; 65(1):53-8. PubMed ID: 2578706
[TBL] [Abstract][Full Text] [Related]
4. Milia in regressing plaques of mycosis fungoides: provoked by topical nitrogen mustard or not?
Kalayciyan A; Oguz O; Demirkesen C; Serdaroglu S; Kotogyan A
Int J Dermatol; 2004 Dec; 43(12):953-6. PubMed ID: 15569030
[TBL] [Abstract][Full Text] [Related]
5. Response of mycosis fungoides to topical chemotherapy with mechlorethamine.
Ramsay DL; Parnes RE; Dubin N
Arch Dermatol; 1984 Dec; 120(12):1585-90. PubMed ID: 6508330
[TBL] [Abstract][Full Text] [Related]
6. Focal contact sensitivity to nitrogen mustard in lesions of cutaneous T-cell lymphoma (mycosis fungoides).
Shelley WB
Acta Derm Venereol; 1981; 61(2):161-4. PubMed ID: 6165197
[TBL] [Abstract][Full Text] [Related]
7. Mechlorethamine desensitization in therapy for mycosis fungoides. Topical desensitization to mechlorethamine (nitrogen mustard) contact hypersensitivity.
Constantine VS; Fuks ZY; Farber EM
Arch Dermatol; 1975 Apr; 111(4):484-8. PubMed ID: 1122150
[TBL] [Abstract][Full Text] [Related]
8. Mycosis fungoides. Topical use of nitrogen mustard in recurrent cases.
Arundell FD; Chan WH
Calif Med; 1968 Dec; 109(6):458-61. PubMed ID: 5724878
[TBL] [Abstract][Full Text] [Related]
9. Remissions of mycosis fungoides induced by nitrogen mustard (HN2). Topical treatment and hydration of tumours and plaques with HN2. Topical desensitization to HN2. A clinical and histopathological controlled study.
Volden G; Larsen TE
Dermatologica; 1978; 156(3):129-41. PubMed ID: 342293
[TBL] [Abstract][Full Text] [Related]
10. Treatment of early-stage mycosis fungoides with twice-weekly applications of mechlorethamine and topical corticosteroids: a prospective study.
de Quatrebarbes J; Estève E; Bagot M; Bernard P; Beylot-Barry M; Delaunay M; D'Incan M; Souteyrand P; Vaillant L; Cordel N; Courville P; Joly P
Arch Dermatol; 2005 Sep; 141(9):1117-20. PubMed ID: 16172308
[TBL] [Abstract][Full Text] [Related]
11. Topical chemotherapy of mycosis fungoides.
Grekin DA; Zackheim HS; Epstein EH
Cutis; 1979 Nov; 24(5):543-6. PubMed ID: 520032
[TBL] [Abstract][Full Text] [Related]
12. [Topical, intratumor and intravenous nitrogen mustard in the treatment of mycosis fungoides (author's transl)].
Sánchez Yus E; Vanaclocha Sebastián F
Med Clin (Barc); 1980 Sep; 75(5):199-202. PubMed ID: 6999251
[TBL] [Abstract][Full Text] [Related]
13. Aspects of the treatment of mycosis fungoides. A report from the Scandinavian Mycosis Fungoides Study Group.
Molin L; Thomsen K; Volden G; Groth O; Fischer T; Nordentoft A; Zachariae H
Cutis; 1980 Feb; 25(2):155-7, 160-1. PubMed ID: 6153595
[TBL] [Abstract][Full Text] [Related]
14. The treatment of mycosis fungoides with ointment-based mechlorethamine.
Price NM; Deneau DG; Hoppe RT
Arch Dermatol; 1982 Apr; 118(4):234-7. PubMed ID: 7065680
[TBL] [Abstract][Full Text] [Related]
15. Transfer factor therapy in mycosis fungoides: a double-blind study.
Thestrup-Pedersen K; Grunnet E; Zachariae H
Acta Derm Venereol; 1982; 62(1):47-53. PubMed ID: 6175137
[TBL] [Abstract][Full Text] [Related]
16. Prolonged remission of tumor-stage mycosis fungoides by topical immunotherpay.
Vonderheid EC; Dellatorre DL; Van Scott EJ
Arch Dermatol; 1981 Sep; 117(9):586-9. PubMed ID: 6457569
[TBL] [Abstract][Full Text] [Related]
17. Complete remissions of mycosis fungoides lymphoma induced by topical nitrogen mustard (HN2). Control of delayed hypersensitivity to HN2 by desensitization and by induction of specific immunologic tolerance.
Van Scott EJ; Kalmanson JD
Cancer; 1973 Jul; 32(1):18-30. PubMed ID: 4577503
[No Abstract] [Full Text] [Related]
18. Clinical stage IA (limited patch and plaque) mycosis fungoides. A long-term outcome analysis.
Kim YH; Jensen RA; Watanabe GL; Varghese A; Hoppe RT
Arch Dermatol; 1996 Nov; 132(11):1309-13. PubMed ID: 8915308
[TBL] [Abstract][Full Text] [Related]
19. Retinoids plus PUVA (RePUVA) and PUVA in mycosis fungoides, plaque stage. A report from the Scandinavian Mycosis Fungoides Group.
Thomsen K; Hammar H; Molin L; Volden G
Acta Derm Venereol; 1989; 69(6):536-8. PubMed ID: 2575334
[TBL] [Abstract][Full Text] [Related]
20. Oral retinoids in mycosis fungoides and Sézary syndrome: a comparison of isotretinoin and etretinate. A study from the Scandinavian Mycosis Fungoides Group.
Molin L; Thomsen K; Volden G; Aronsson A; Hammar H; Hellbe L; Wantzin GL; Roupe G
Acta Derm Venereol; 1987; 67(3):232-6. PubMed ID: 2442936
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]